바로가기 및 건너띄기 링크: 본문 바로가기; 주메뉴 바로가기

알림마당

공지사항

home 알림마당 공지사항

제약산업정보포털 신규 초빙 해외제약전문가 컨설팅 안내

제약산업정보포털 신규 초빙 해외제약전문가 컨설팅 안내 : 작성자, 작성일, 조회수, 정보 제공
작성자	관리자
작성일	2017-09-14	조회수	11,011

신규 초빙 해외제약전문가 컨설팅 안내

한국보건산업진흥원에서는 의약품 개발 각 분야의 해외 전문가들을 상임 컨설턴트로 초빙하여

제약 기업과 유관 기관에게 무료로 컨설팅을 제공하고 있습니다.

오는 9월 21일부터 Ravil Niyajov 박사께서 새로이 초빙되어 러시아/CIS 지역 인허가 및 임상분야 컨설팅을 제공할 예정입니다.

Ravil Niyajov 박사의 상세 이력은 컨설팅 홈페이지( http://www.epharmakorea.or.kr/gpkol) 에 소개되어 있으며,

컨설팅을 원하시는 분은 컨설팅 홈페이지를 통하여 신청하실 수 있습니다,

관련된 자세한 사항은 박미소 연구원(miso0703@khidi.or.kr, 043-710-0024)에게 문의하시길 바랍니다.

이름	Ravil Niyajov (라빌 니야조프) / 러시아/CIS 지역
소속/직위	KHIDI 해외제약전문가 상임 컨설턴트
컨설팅 분야	인허가 - 러시아/CIS 지역 제품 등록 및 인허가 - 의약품 전략적 관리 임상시험 - 러시아/CIS 내 임상시험 설계
주요 약력	· 러시아 보건부 산하 FSBI 의약품 심사관 (7년) · Center of Scientific Advice Ltd. Head of clinical and regulatory affairs department (2년) · Eurasian Economic Commission 현 위원 (유라시아경제연합체(EAEU)의 의약품 인허가 규정 수립)

이전글 글로벌 제약산업 핵심전문가(GPKOL) 위원 선정 공고
다음글 GHKOL 의료해외진출 전략 세미나 및 현장 컨설팅 개최 ( 9/12 )

연관컨텐츠: 해외제약전문가 컨설팅 제약산업 제약산업정보포털 의약품

<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">신규 초빙 해외제약전문가 컨설팅 안내
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;"> 
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">한국보건산업진흥원에서는 의약품 개발 각 분야의 해외
전문가들을 상임 컨설턴트로 초빙하여 
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">제약 기업과 유관 기관에게 무료로 컨설팅을 제공하고 있습니다.
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;"> 
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">오는 9월 21일부터 Ravil Niyajov 박사께서 새로이 초빙되어 러시아/CIS 지역 인허가 및 임상분야 컨설팅을 제공할 예정입니다.
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">Ravil Niyajov 박사의 상세 이력은 컨설팅 홈페이지(<a href="http://www.epharmakorea.or.kr/gpkol"> </a><a href="http://www.epharmakorea.or.kr/gpkol">http://www.epharmakorea.or.kr/gpkol</a>) 에 소개되어 있으며, 
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">컨설팅을 원하시는 분은 컨설팅 홈페이지를 통하여 신청하실 수 있습니다, 
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;"> 
<p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">관련된 자세한 사항은 박미소 연구원(miso0703@khidi.or.kr, 043-710-0024)에게 문의하시길 바랍니다.
 
<table style="margin: auto auto auto 6pt; width: 657px; border-collapse: collapse; mso-yfti-tbllook: 1184;" border="0" cellspacing="0" cellpadding="0"> 
<tbody>
<tr style="height: 29.8pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes;"> 
<td width="79" style="border-width: 2px 1px 1px 2px; border-style: solid; border-color: black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 29.8pt; background-color: transparent; mso-border-top-alt: 1.5pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
이름 </td> 
<td width="396" style="border-width: 2px 1px 1px 0px; border-style: solid solid solid none; border-color: black black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 371px; height: 29.8pt; background-color: transparent; mso-border-top-alt: 1.5pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
Ravil Niyajov (라빌 니야조프) / 러시아/CIS 지역 </td> 
<td width="155" style="border-width: 2px 2px 1px 0px; border-style: solid solid solid none; border-color: black black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 191px; height: 29.8pt; background-color: transparent; mso-border-top-alt: 1.5pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: 1.5pt; mso-border-color-alt: black; mso-border-style-alt: solid;" rowspan="3"> 
<img width="148" height="149" title="external_image" align="left" alt="EMB00001a90421d" src="http://www.khidi.or.kr/resources/component/crosseditor/binary/images/images/000035/20170914182431948_GXH3NLSM.png" hspace="12" v:shapes="_x130626456"> </td> 
</tr> 
<tr style="height: 32.65pt; mso-yfti-irow: 1;"> 
<td width="79" style="border-width: 0px 1px 1px 2px; border-style: none solid solid; border-color: rgb(0, 0, 0) black black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 32.65pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
소속/직위 </td> 
<td width="396" style="border-width: 0px 1px 1px 0px; border-style: none solid solid none; border-color: rgb(0, 0, 0) black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 371px; height: 32.65pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
KHIDI 해외제약전문가 상임 컨설턴트 </td> 
</tr> 
<tr style="height: 91.45pt; mso-yfti-irow: 2;"> 
<td width="79" style="border-width: 0px 1px 1px 2px; border-style: none solid solid; border-color: rgb(0, 0, 0) black black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 91.45pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
컨설팅 분야 </td> 
<td width="396" style="border-width: 0px 1px 1px 0px; border-style: none solid solid none; border-color: rgb(0, 0, 0) black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 371px; height: 91.45pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
인허가 
- 러시아/CIS 지역 제품 등록 및 인허가 
- 의약품 전략적 관리 
임상시험 
- 러시아/CIS 내 임상시험 설계 </td> 
</tr> 
<tr style="height: 75.35pt; mso-yfti-irow: 3; mso-yfti-lastrow: yes;"> 
<td width="79" style="border-width: 0px 1px 2px 2px; border-style: none solid solid; border-color: rgb(0, 0, 0) black black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 75.35pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: 1.5pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 
주요 약력 </td> 
<td width="551" style="border-width: 0px 2px 2px 0px; border-style: none solid solid none; border-color: rgb(0, 0, 0) black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 509px; height: 75.35pt; background-color: transparent; mso-border-top-alt: solid black .25pt; mso-border-left-alt: solid black .5pt;" colspan="2"> 
· 러시아 보건부 산하 FSBI 의약품
 심사관 (7년) 
· Center of Scientific
 Advice Ltd. Head of clinical and regulatory affairs department (2년) 
· Eurasian Economic
 Commission 현 위원 
 (유라시아경제연합체(EAEU)의
 의약품 인허가 규정 수립) </td> 
</tr>
</tbody>
</table>

html 소스복사 <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">신규 초빙 해외제약전문가 컨설팅 안내 <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;"> <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">한국보건산업진흥원에서는 의약품 개발 각 분야의 해외 전문가들을 상임 컨설턴트로 초빙하여 <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">제약 기업과 유관 기관에게 무료로 컨설팅을 제공하고 있습니다. <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;"> <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">오는 9월 21일부터 Ravil Niyajov 박사께서 새로이 초빙되어 러시아/CIS 지역 인허가 및 임상분야 컨설팅을 제공할 예정입니다. <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">Ravil Niyajov 박사의 상세 이력은 컨설팅 홈페이지(<a href="http://www.epharmakorea.or.kr/gpkol"> </a><a href="http://www.epharmakorea.or.kr/gpkol">http://www.epharmakorea.or.kr/gpkol</a>) 에 소개되어 있으며, <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">컨설팅을 원하시는 분은 컨설팅 홈페이지를 통하여 신청하실 수 있습니다, <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;"> <p align="left" style="margin: 0cm 0cm 0pt; text-align: left; -ms-word-break: keep-all; tab-stops: 18.0pt 36.0pt 54.0pt 72.0pt 90.0pt 108.0pt 126.0pt 144.0pt 162.0pt 180.0pt 198.0pt 216.0pt 234.0pt 252.0pt 270.0pt 288.0pt 306.0pt 324.0pt 342.0pt 360.0pt 378.0pt 396.0pt 414.0pt 432.0pt 450.0pt 468.0pt 486.0pt 504.0pt 522.0pt 540.0pt 558.0pt 576.0pt; mso-layout-grid-align: none;">관련된 자세한 사항은 박미소 연구원(miso0703@khidi.or.kr, 043-710-0024)에게 문의하시길 바랍니다. <table style="margin: auto auto auto 6pt; width: 657px; border-collapse: collapse; mso-yfti-tbllook: 1184;" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr style="height: 29.8pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes;"> <td width="79" style="border-width: 2px 1px 1px 2px; border-style: solid; border-color: black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 29.8pt; background-color: transparent; mso-border-top-alt: 1.5pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 이름 </td> <td width="396" style="border-width: 2px 1px 1px 0px; border-style: solid solid solid none; border-color: black black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 371px; height: 29.8pt; background-color: transparent; mso-border-top-alt: 1.5pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> Ravil Niyajov (라빌 니야조프) / 러시아/CIS 지역 </td> <td width="155" style="border-width: 2px 2px 1px 0px; border-style: solid solid solid none; border-color: black black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 191px; height: 29.8pt; background-color: transparent; mso-border-top-alt: 1.5pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: 1.5pt; mso-border-color-alt: black; mso-border-style-alt: solid;" rowspan="3"> <img width="148" height="149" title="external_image" align="left" alt="EMB00001a90421d" src="http://www.khidi.or.kr/resources/component/crosseditor/binary/images/images/000035/20170914182431948_GXH3NLSM.png" hspace="12" v:shapes="_x130626456"> </td> </tr> <tr style="height: 32.65pt; mso-yfti-irow: 1;"> <td width="79" style="border-width: 0px 1px 1px 2px; border-style: none solid solid; border-color: rgb(0, 0, 0) black black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 32.65pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 소속/직위 </td> <td width="396" style="border-width: 0px 1px 1px 0px; border-style: none solid solid none; border-color: rgb(0, 0, 0) black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 371px; height: 32.65pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> KHIDI 해외제약전문가 상임 컨설턴트 </td> </tr> <tr style="height: 91.45pt; mso-yfti-irow: 2;"> <td width="79" style="border-width: 0px 1px 1px 2px; border-style: none solid solid; border-color: rgb(0, 0, 0) black black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 91.45pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 컨설팅 분야 </td> <td width="396" style="border-width: 0px 1px 1px 0px; border-style: none solid solid none; border-color: rgb(0, 0, 0) black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 371px; height: 91.45pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: .5pt; mso-border-bottom-alt: .25pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 인허가 - 러시아/CIS 지역 제품 등록 및 인허가 - 의약품 전략적 관리 임상시험 - 러시아/CIS 내 임상시험 설계 </td> </tr> <tr style="height: 75.35pt; mso-yfti-irow: 3; mso-yfti-lastrow: yes;"> <td width="79" style="border-width: 0px 1px 2px 2px; border-style: none solid solid; border-color: rgb(0, 0, 0) black black; padding: 1.4pt 5.1pt; width: 59.6pt; height: 75.35pt; background-color: transparent; mso-border-top-alt: .25pt; mso-border-left-alt: 1.5pt; mso-border-bottom-alt: 1.5pt; mso-border-right-alt: .5pt; mso-border-color-alt: black; mso-border-style-alt: solid;"> 주요 약력 </td> <td width="551" style="border-width: 0px 2px 2px 0px; border-style: none solid solid none; border-color: rgb(0, 0, 0) black black rgb(0, 0, 0); padding: 1.4pt 5.1pt; width: 509px; height: 75.35pt; background-color: transparent; mso-border-top-alt: solid black .25pt; mso-border-left-alt: solid black .5pt;" colspan="2"> · 러시아 보건부 산하 FSBI 의약품 심사관 (7년) · Center of Scientific Advice Ltd. Head of clinical and regulatory affairs department (2년) · Eurasian Economic Commission 현 위원 (유라시아경제연합체(EAEU)의 의약품 인허가 규정 수립) </td> </tr> </tbody> </table>
소스입니다. Ctrl+C를 눌러 클립보드로 복사하세요

산업별사이트 바로가기

KHIDI 한국보건산업진흥원

전체메뉴

알림마당

공지사항

제약산업정보포털 신규 초빙 해외제약전문가 컨설팅 안내

관련기관 배너모음